162 related articles for article (PubMed ID: 36660636)
1. Analysis of gut microbiota in patients with acute myocardial infarction by 16S rRNA sequencing.
Qian X; Liu A; Liang C; He L; Xu Z; Tang S
Ann Transl Med; 2022 Dec; 10(24):1340. PubMed ID: 36660636
[TBL] [Abstract][Full Text] [Related]
2. Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction.
Han Y; Gong Z; Sun G; Xu J; Qi C; Sun W; Jiang H; Cao P; Ju H
Front Microbiol; 2021; 12():680101. PubMed ID: 34295318
[TBL] [Abstract][Full Text] [Related]
3. Specific gut microbiome and metabolome changes in patients with continuous ambulatory peritoneal dialysis and comparison between patients with different dialysis vintages.
Li J; Xing H; Lin W; Yu H; Yang B; Jiang C; Zhang J; Wu R; Ding F; Pei M; Yang H
Front Med (Lausanne); 2023; 10():1302352. PubMed ID: 38249961
[TBL] [Abstract][Full Text] [Related]
4. Luhong Granules Prevent Ventricular Remodelling after Myocardial Infarction by Reducing the Metabolites TMAO and LPS of the Intestinal Flora.
Yang T; Qu H; Song X; Liu Q; Yang X; Xu J; Yang T; Lan Z; Sha W; Zhou H
Evid Based Complement Alternat Med; 2019; 2019():8937427. PubMed ID: 31827566
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.
Dong C; Yang Y; Wang Y; Hu X; Wang Q; Gao F; Sun S; Liu Q; Li L; Liu J; Tang Y; Zhang S; Wu C; Zhu H
J Adv Res; 2023 Apr; 46():101-112. PubMed ID: 35750287
[TBL] [Abstract][Full Text] [Related]
6. Integrated 16S rRNA Gene Sequencing and LC-MS Analysis Revealed the Interplay Between Gut Microbiota and Plasma Metabolites in Rats With Ischemic Stroke.
Wu W; Sun Y; Luo N; Cheng C; Jiang C; Yu Q; Cheng S; Ge J
J Mol Neurosci; 2021 Oct; 71(10):2095-2106. PubMed ID: 33954858
[TBL] [Abstract][Full Text] [Related]
7. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
8. Microbiome-metabolome reveals that the Suxiao Jiuxin pill attenuates acute myocardial infarction associated with fatty acid metabolism.
Liao J; Zhang Y; Ma C; Wu G; Zhang W
J Ethnopharmacol; 2023 Aug; 312():116529. PubMed ID: 37086873
[TBL] [Abstract][Full Text] [Related]
9. Compositional alterations of the gut microbiota in acute myocardial infarction patients with type 2 diabetes mellitus.
Lei C; Zhang X; Chen E; Lin L; Zhou Z; Wang Z; Liu T; Liu Z
Ann Transl Med; 2023 Jun; 11(9):317. PubMed ID: 37405000
[TBL] [Abstract][Full Text] [Related]
10. Analysis of two intestinal bacterial metabolites (trimethylamine N-oxide and phenylacetylglutamine) in human serum samples of patients with T2DM and AMI using a liquid chromatography tandem mass spectrometry method.
Tang Y; Zou Y; Cui J; Ma X; Zhang L; Yu S; Qiu L
Clin Chim Acta; 2022 Nov; 536():162-168. PubMed ID: 36191613
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
[No Abstract] [Full Text] [Related]
12. The changes of gut microbiota after acute myocardial infarction in rats.
Wu ZX; Li SF; Chen H; Song JX; Gao YF; Zhang F; Cao CF
PLoS One; 2017; 12(7):e0180717. PubMed ID: 28686722
[TBL] [Abstract][Full Text] [Related]
13. Serological short-chain fatty acid and trimethylamine N-oxide microbial metabolite imbalances in young adults with acute myocardial infarction.
Avendaño-Ortiz J; Lorente-Ros Á; Briones-Figueroa A; Morán-Alvarez P; García-Fernández A; Garrote-Corral S; Amil-Casas I; Carrasco-Sayalero Á; Tejada-Velarde A; Camino-López A; Jiménez-Mena M; Del Campo R; Villalobos-Sánchez L; García-Villanueva MJ
Heliyon; 2023 Oct; 9(10):e20854. PubMed ID: 37867899
[TBL] [Abstract][Full Text] [Related]
14. [Distribution characteristics of trimethylamine N-oxide and its association with gut microbiota].
Wang S; Xia GH; He Y; Liao SX; Yin J; Sheng HF; Zhou HW
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):455-60. PubMed ID: 27113169
[TBL] [Abstract][Full Text] [Related]
15. Cecal Gut Microbiota and Metabolites Might Contribute to the Severity of Acute Myocardial Ischemia by Impacting the Intestinal Permeability, Oxidative Stress, and Energy Metabolism.
Sun L; Jia H; Li J; Yu M; Yang Y; Tian D; Zhang H; Zou Z
Front Microbiol; 2019; 10():1745. PubMed ID: 31428065
[TBL] [Abstract][Full Text] [Related]
16. The gut microbiome and microbial metabolites in acute myocardial infarction.
Liu C; Sun Z; Shali S; Mei Z; Chang S; Mo H; Xu L; Pu Y; Guan H; Chen GC; Qi Q; Quan Z; Qi J; Yao K; Dai Y; Zheng Y; Ge J
J Genet Genomics; 2022 Jun; 49(6):569-578. PubMed ID: 34974193
[TBL] [Abstract][Full Text] [Related]
17. Diversified Shifts in the Cross Talk between Members of the Gut Microbiota and Development of Coronary Artery Diseases.
Zhang T; Ren H; Du Z; Zou T; Guang X; Zhang Y; Tian Y; Zhu L; Yu J; Yu X; Zhang Z; Dai H
Microbiol Spectr; 2022 Dec; 10(6):e0280422. PubMed ID: 36301099
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentration of TMAO is an independent predictor of adverse outcomes in patients after acute myocardial infarction.
Gąsecka A; Fidali O; Kłębukowska A; Jasińska-Gniadzik K; Szwed P; Witkowska K; Eyileten C; Postuła M; Grabowski M; Filipiak KJ; Ufnal M
Postepy Kardiol Interwencyjnej; 2023 Mar; 19(1):31-39. PubMed ID: 37090218
[TBL] [Abstract][Full Text] [Related]
19. Ethanol extract of Pueraria lobata improve acute myocardial infarction in rats via regulating gut microbiota and bile acid metabolism.
Zhang P; Fang Z; Zhao M; Yi B; Huang Y; Yang H; Guo N; Zhao C
Phytother Res; 2023 Dec; 37(12):5932-5946. PubMed ID: 37697496
[TBL] [Abstract][Full Text] [Related]
20. Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome.
Ringel C; Dittrich J; Gaudl A; Schellong P; Beuchel CF; Baber R; Beutner F; Teren A; Engel C; Wirkner K; Thiele H; Büttner P; Löffler M; Scholz M; Thiery J; Ceglarek U
Atherosclerosis; 2021 Oct; 335():62-67. PubMed ID: 34583200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
